61 – 68 of 68
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1997
-
Mark
Activated protein C resistance : Clinical implications
(
- Contribution to journal › Scientific review
- 1996
-
Mark
Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries
(
- Contribution to journal › Article
-
Mark
Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis
(
- Contribution to journal › Scientific review
-
Mark
High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
(
- Contribution to journal › Letter
-
Mark
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance as a basis for venous thrombosis.
(
- Contribution to journal › Article
- 1995
-
Mark
Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
(
- Contribution to journal › Article
-
Mark
The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues
(
- Contribution to journal › Article